Zalicus

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Zalicus is an American biomedical company headquartered in Cambridge, Massachusetts. The company is finding new ways to cure pain. In 2013, Zalicus dropped Z160, a painkiller that would treat pain from shingles. The stock symbol is ZLCS.

References[edit]